Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pathophysiologic aspects of systemic sclerosis].

Jan Tore Gran1, Øyvind Molberg, Øyvind Midtvedt

  • 1Revmatologisk avdeling, Rikshospitalet 0027 Oslo. jan.tore.gran@rikshospitalet.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|October 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026
Same author

Lifetime risk of malignancy in polymyalgia rheumatica: a population-based matched cohort study from southern Norway.

Rheumatology (Oxford, England)·2026
Same author

Reply.

Arthritis care & research·2026
Same author

Clinical Profiles and Lung Function Trajectories of Patients With IIM-ILD: A Comparative Study of Pulmonology and Rheumatology Settings.

Chest·2026
Same author

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

European journal of internal medicine·2026
Same author

Cryoglobulinemia Type II: Sustained Remission After B-Cell-Directed Therapy.

The American journal of case reports·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Systemic sclerosis involves organ fibrosis and immune dysfunction. New insights into fibrosis regulation by molecules like TGF-β may lead to novel therapeutic strategies beyond managing complications.

Area of Science:

  • Immunology
  • Fibrosis Research
  • Dermatology

Background:

  • Systemic sclerosis (SSc) is characterized by severe organ fibrosis, vascular obliteration, and immune system disturbances.
  • Recent research has illuminated the complex pathogenesis of SSc, suggesting potential for new therapeutic interventions.

Purpose of the Study:

  • To review the current understanding of fibrosis regulation in systemic sclerosis.
  • To highlight key molecules involved in the fibrotic process.

Main Methods:

  • A review of relevant medical literature was conducted.

Main Results:

  • Pathological extracellular matrix deposition in SSc is likely due to altered dermal fibroblast regulation.
  • The review focuses on three critical fibrotic molecules: Transforming growth factor beta (TGF-β), Connective tissue growth factor (CTGF), and Endothelin-1 (ET-1).

Related Experiment Videos

Conclusions:

  • Historically, treatment for SSc focused on organ-specific complications.
  • Emerging knowledge of fibrotic processes is driving new therapeutic trials targeting pro-fibrotic molecules.